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summarY – patent foramen ovale (pfo) can be found in approximately 25% of adult popu-
lation. Transcatheter closure of pfo is a potential option in selected patients with pfo. We report 
a case of a female patient that underwent mapping and catheter ablation of atrial tachycardia and 
pfo closure in the same procedure. 
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Introduction
The prevalence of patent foramen ovale (pfo) is 
estimated at 15%-25% in adult population according 
to previous studies1,2, and the prevalence of atrial sep-
tal aneurysm at 2%-3%1. in patients with cryptogenic 
stroke, pfo was found in 43% of younger patients 
and 28% in older patients in the study by handke et 
al.3. 
although catheter closure of pfo is a matter of 
debate and current american heart association/
american stroke association guidelines for stroke 
prevention give it class iib recommendation4, studies 
that compared closure with medical treatment showed 
a trend toward better outcomes in patients that under-
went closure of pfo, especially those with more than 
one stroke5.
results from ongoing randomized trials are 
needed to answer the question regarding efficacy and 
safety of percutaneous closure of pfo compared to 
medical therapy only. atrial arrhythmias are reported 
to occur more often in patients after pfo closure6, 
whereas our patient presented with atrial tachycardia 
before the closure.
Case Report
a 60-year-old female with a history of hypertension 
presented to the cardiology outpatient clinic because of 
palpitation and nonspecific chest pain. in her medical 
history, she suffered a transient ischemic attack 8 years 
before and ischemic stroke 5 years before. her physi-
cal examination was unremarkable, her blood pressure 
was 140/90 mm hg, pulse 70/min and respirations 
were 14/min. The patient was taking aspirin 100 mg, 
propafenone 150 mg three times daily, candesartan 8 
mg daily and atorvastatin 20 mg. 
electrocardiography (ecg) showed normal sinus 
rhythm, pr interval 160 ms, and normal axis. chest 
x-ray was normal as well as standard laboratory results. 
The patient was scheduled for 24-hour ecg, 
ecg stress test and echocardiography. ecg stress 
test was normal with no signs of arrhythmias, while 
24-hour ecg showed a total of 18 non sustained and 
2 sustained supraventricular tachycardias.
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echocardiography showed normal size of the ven-
tricles, no dilatation of the atria, with left ventricular 
ejection fraction 60%. Transesophageal echocardiog-
raphy was performed due to her history of recurrent 
stroke and showed pfo with clear right to left flow 
during the release phase of valsalva maneuver. The 
size of the septum in fossa ovalis was 21 mm with 
4.5 mm aortic rim. There was no thrombus in the left 
atrial appendage, with normal flow.
since the patient had recurrent ischemic stroke in her 
medical history, indication for pfo closure was made. 
also, the patient had palpitations with proven supraven-
tricular tachycardia, which was highly symptomatic. 
after informing the patient, she was scheduled for 
electrophysiology (ep) study and transcatheter clo-
sure of pfo in the same procedure. 
The ep study was performed after propafenone 
had been discontinued for 5 days and using minimal 
sedation. four catheters were placed: coronary sinus 
catheter (10 pole), his bundle catheter (8 pole), right 
ventricle catheter (4 pole) and mapping catheter for 
3d mapping (navistar, d curve). during the ep 
study, spontaneous atrial tachycardia occurred (fig. 
Fig. 1. 12-lead electrocardiogram of clinical atrial tachycardia recorded in the electrophysiology laboratory.
1). The tachycardia could also be induced using iso-
proterenol infusion.
activation mapping of both the left and right atria 
was performed (catheter for la mapping was intro-
duced through pfo) and the superior vena cava os-
tium was identified as the origin of atrial tachycardia. 
a total of 300 s of rf energy (40W, 48c) was applied 
to the svc ostium and the tachycardia was interrupt-
ed (fig. 2). after the ablation procedure, tachycardia 
did not occur spontaneously or after isoproterenol in-
fusion. 
after the ablation, the guide wire was passed 
across the pfo and than pfo closure was performed 
under fluoroscopy and transesophageal echocardiog-
raphy guidance using figulla occlutech 23/25 mm 
closure device (fig. 3). 
The procedure was carried out without complica-
tions and the patient was discharged 2 days later with 
aspirin 100 mg, clopidogrel 75 mg, candesartan 8 mg, 
atorvastatin 20 mg and bisoprolol 2.5 mg. 
on regular 3-month follow up, the patient was 
feeling well, had no symptoms and her 24-hour ecg 
showed no arrhythmia.
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Discussion
We report a case of a 60-year-old female who un-
derwent rf ablation of atrial tachycardia and pfo 
closure in the same procedure. There are previous re-
ports on successful rf ablation with closure of pfo 
identified during the ep study7. This report describes 
a patient where pfo was diagnosed during the ep 
study7, whereas we diagnosed pfo before the ep 
study. although we diagnosed pfo before the ep 
procedure, there are several clinical problems that 
may have occurred. 
first, the patient’s tachycardia was not verified in 
12 lead ecg before the procedure, so the possible 
origin could not be identified. if the pfo was closed 
before the ep study, it may have posed a difficulty if 
tachycardia would be found to originate from the left 
atrium or pulmonary veins. There are reports on the 
safety of transseptal puncture in patients with closure 
devices8, but it should be avoided if possible. 
Fig. 2. Anteroposterior view 
on CARTO XP showing 
right atrium and ablation 
area in superior vena cava 
(SVC) ostium. 
Fig. 3. Left anterior oblique (LAO) view of patent 
foramen ovale closure device in place.
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on the other hand, if the ablation was performed 
first and pfo closure was performed as another pro-
cedure, the patient would have undergone two rou-
tine but still invasive procedures, as well as a probably 
higher risk of paradoxical embolism after the first rf 
ablation. 
so, after explaining the risks and benefits to the 
patient, these two procedures were performed in one 
act with no complications. pfo closure added 20 
minutes to the total procedure, with less than 1 min-
ute fluoroscopy time added to the procedure. 
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sažetak
TransKaTeTersKo ZaTvaranJe oTvorenog foramena ovale i radiofreKvenTna 
ablaciJa aTriJsKe TahiKardiJe iZ desnog aTriJa 
Š. Manola, R. Bernat, N. Pavlović, V. Radeljić, N. Bulj i M. Trbušić
otvoreni foramen ovale (pfo) može se naći u gotovo 25% populacije. Katetersko zatvaranje pfo je terapijska opcija 
u određenog broja bolesnika. prikazujemo slučaj bolesnice kojoj je u istom aktu učinjeno mapiranje i ablacija atrijske tahi-
kardije te zatvaranje pfo-a. 
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